Chairman hails Guidant results as "truly extraordinary"
This article was originally published in Clinica
Guidant achieved sales for the first six months of this year almost as large as its entire annual sales of two years ago and made nearly as much profit as 1997's full year figures. The second quarter, with sales up 73% and earnings rising 137% on the same period last year, prompted the company's chairman, James Cornelius, to call the results so far this year "truly extraordinary".
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.